Additional file 4: Table S4. of Erratum to: An exploratory randomised double-blind and placebo-controlled phase 2 study of a combination of baclofen, naltrexone and sorbitol (PXT3003) in patients with Charcot-Marie-Tooth disease type 1A
Response to PXT3003 on efficacy outcomes (Full Analysis Set, n = 80). Data are mean (s.d.) baseline and final values, and % (s.d.) of improvement for each treatment group and PLI. Differences between treatment groups were assessed by Analysis of Covariance (Ancova) on log-transformed values by adjus...
Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Format: | Text |
Language: | unknown |
Published: |
figshare
2019
|
Subjects: | |
Online Access: | https://dx.doi.org/10.6084/m9.figshare.10037333 https://springernature.figshare.com/articles/Additional_file_4_Table_S4_of_Erratum_to_An_exploratory_randomised_double-blind_and_placebo-controlled_phase_2_study_of_a_combination_of_baclofen_naltrexone_and_sorbitol_PXT3003_in_patients_with_Charcot-Marie-Tooth_disease_type_1A/10037333 |